78 related articles for article (PubMed ID: 18338401)
1. Diagnostics in the shadow of HIV epidemics.
Janossy G; Mandy F; O'Gorman MR
Cytometry B Clin Cytom; 2008; 74 Suppl 1():S1-3. PubMed ID: 18338401
[TBL] [Abstract][Full Text] [Related]
2. Large-scale affordable PanLeucogated CD4+ testing with proactive internal and external quality assessment: in support of the South African national comprehensive care, treatment and management programme for HIV and AIDS.
Glencross DK; Janossy G; Coetzee LM; Lawrie D; Aggett HM; Scott LE; Sanne I; McIntyre JA; Stevens W
Cytometry B Clin Cytom; 2008; 74 Suppl 1():S40-51. PubMed ID: 18228554
[TBL] [Abstract][Full Text] [Related]
3. Simplified cytometry for routine monitoring of infectious diseases.
Janossy G; Shapiro H
Cytometry B Clin Cytom; 2008; 74 Suppl 1():S6-10. PubMed ID: 18228555
[TBL] [Abstract][Full Text] [Related]
4. Access to diagnostics in support of HIV/AIDS and tuberculosis treatment in developing countries.
Cohen GM
AIDS; 2007 Jul; 21 Suppl 4():S81-7. PubMed ID: 17620757
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometry as the spearhead for delivering sustainable and versatile laboratory services to HIV-burdened health care systems of the developing world: a Caribbean model.
Abayomi EA; Landis RC
Cytometry B Clin Cytom; 2008; 74 Suppl 1():S80-9. PubMed ID: 18228563
[TBL] [Abstract][Full Text] [Related]
6. African regional external quality assessment for CD4 T-cell enumeration: development, outcomes, and performance of laboratories.
Glencross DK; Aggett HM; Stevens WS; Mandy F
Cytometry B Clin Cytom; 2008; 74 Suppl 1():S69-79. PubMed ID: 18228560
[TBL] [Abstract][Full Text] [Related]
7. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.
Bennett DE; Bertagnolio S; Sutherland D; Gilks CF
Antivir Ther; 2008; 13 Suppl 2():1-13. PubMed ID: 18578063
[TBL] [Abstract][Full Text] [Related]
8. Decentralization of CD4 testing in resource-limited settings: 7 years of experience in six African countries.
Marinucci F; Medina-Moreno S; Paterniti AD; Wattleworth M; Redfield RR
Cytometry A; 2011 May; 79(5):368-74. PubMed ID: 21495181
[TBL] [Abstract][Full Text] [Related]
9. The changing pattern of "smart" flow cytometry (S-FC) to assist the cost-effective diagnosis of HIV, tuberculosis, and leukemias in resource-restricted conditions.
Janossy G
Biotechnol J; 2008 Jan; 3(1):32-42. PubMed ID: 18064612
[TBL] [Abstract][Full Text] [Related]
10. The fragile environments of inexpensive CD4+ T-cell enumeration in the least developed countries: strategies for accessible support.
Larsen CH
Cytometry B Clin Cytom; 2008; 74 Suppl 1():S107-16. PubMed ID: 18228565
[TBL] [Abstract][Full Text] [Related]
11. Operational challenges in delivering CD4 diagnostics in sub-Saharan Africa.
Thairu L; Katzenstein D; Israelski D
AIDS Care; 2011 Jul; 23(7):814-21. PubMed ID: 21400312
[TBL] [Abstract][Full Text] [Related]
12. From research tool to routine test: CD38 monitoring in HIV patients.
Coetzee LM; Tay SS; Lawrie D; Janossy G; Glencross DK
Cytometry B Clin Cytom; 2009 Nov; 76(6):375-84. PubMed ID: 19422053
[TBL] [Abstract][Full Text] [Related]
13. Research needs and challenges in the development of HIV diagnostic and treatment monitoring tests for use in resource-limited settings.
Cheng B; Landay A; Miller V
Curr Opin HIV AIDS; 2008 Jul; 3(4):495-503. PubMed ID: 19373011
[TBL] [Abstract][Full Text] [Related]
14. World Health Organization/HIVResNet Drug Resistance Laboratory Strategy.
Bertagnolio S; Derdelinckx I; Parker M; Fitzgibbon J; Fleury H; Peeters M; Schuurman R; Pillay D; Morris L; Tanuri A; Gershy-Damet GM; Nkengasong J; Gilks CF; Sutherland D; Sandstrom P
Antivir Ther; 2008; 13 Suppl 2():49-57. PubMed ID: 18575191
[TBL] [Abstract][Full Text] [Related]
15. The global health and diagnostic (flow) cytometry--breakthroughs in HIV and tuberculosis.
Merson M; Denny TN
Cytometry B Clin Cytom; 2008; 74 Suppl 1():S4-5. PubMed ID: 18307250
[No Abstract] [Full Text] [Related]
16. Building laboratory infrastructure to support scale-up of HIV/AIDS treatment, care, and prevention: in-country experience.
Abimiku AG;
Am J Clin Pathol; 2009 Jun; 131(6):875-86. PubMed ID: 19461097
[TBL] [Abstract][Full Text] [Related]
17. CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals.
Kolber MA
AIDS; 2008 Oct; 22(15):1937-41. PubMed ID: 18784457
[TBL] [Abstract][Full Text] [Related]
18. Challenges in implementing CD4 testing in resource-limited settings.
Peter T; Badrichani A; Wu E; Freeman R; Ncube B; Ariki F; Daily J; Shimada Y; Murtagh M
Cytometry B Clin Cytom; 2008; 74 Suppl 1():S123-30. PubMed ID: 18348208
[TBL] [Abstract][Full Text] [Related]
19. Immunologic features of HIV-1-infected women on HAART at delivery.
Ono E; Dos Santos AM; Machado DM; Succi RC; Amed AM; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2008 Jul; 74(4):236-43. PubMed ID: 18393385
[TBL] [Abstract][Full Text] [Related]
20. Optimal HIV testing and earlier care: the way forward in Europe.
Coenen T; Lundgren J; Lazarus JV; Matic S
HIV Med; 2008 Jul; 9 Suppl 2():1-5. PubMed ID: 18557862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
